Healthcare -
Biotechnology - NASDAQ - US
$ 1.31
2.34 %
$ 83 M
Market Cap
-1.44
P/E
Price Target
Average
205.34%
Revenue Forecast
Estimate
107.21%
EBIT
Estimate
2.16%
Net Income
Estimate
39.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cue Biopharma, Inc.
Wall Street analysts predict an average 1-year price target for CUE of $4 , with forecasts ranging from
a
low of
$2 to a high of $6 .
CUE Lowest Price Target
Wall Street Target
2 USD
52.67%
CUE Average Price Target
Wall Street Target
4 USD
205.34%
CUE Highest Price Target
Wall Street Target
6 USD
358.02%
REVENUE FORECAST
Revenue Forecast Chart CUE
EBIT FORECAST
EBIT Forecast Chart CUE
NET INCOME FORECAST
Net Income Chart CUE